deficit in Biological Technology
Navigation Links
deficit in Biological Technology
Spectral announces first quarter 2009 results
... 5,716 5,716 deficit ... Statements of Operations, Comprehensive Loss and deficit - unaudited For the three months ended March ... for the period (404) (448) deficit - Beginning of period ...Spectral announces 2008 financial results
... 5,716 5,606 deficit ... the year (1,502) (1,666) deficit - Beginning of year (2,687) ... ---------------------------- deficit - End of year (4,189) ...... VYVANSE - for use in the treatment of attention deficit and hyperactivity disorder ("ADHD") in children ... Shire focuses its business on attention deficit and hyperactivity disorder ("ADHD"), human ... 97.0 55.7 Accumulated deficit (1,051.7) ...
Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results
... 511,866 502,163 Accumulated deficit (642,053) (576,501) Total stockholders' deficit (130,187) (74,338) Total liabilities and stockholders' deficit $263,002 $183,050 ...Spectral announces third quarter 2008 results
... 5,671 5,606 deficit ... Statements of Operations, Comprehensive Loss and deficit - unaudited For the nine months ended September ... (332) (382) (1,199) (968) deficit - Beginning of period ...Shire's New Product Portfolio Delivers Strong Quarterly Performance
... (lisdexamfetamine dimesylate) - Attention deficit and Hyperactivity Disorder ("ADHD") - The ... (lisdexamfetamine dimesylate) (Attention deficit and Hyperactivity Disorder ("ADHD")); the impact ... 85.6 55.7 Accumulated deficit (1,115.1) ...Monogram Announces 2008 Third Quarter Financial Results
... $69,311 LIABILITIES AND STOCKHOLDERS' deficit Current liabilities: Accounts payable ... - (31) Accumulated deficit (299,714) (287,539) Total stockholders' deficit (8,945) (1,240) ...Celebrity Designer Ty Pennington to Host 10th Annual 'ADHD Experts on Call' Program
... ADHD Experts to Answer Questions about Attention deficit Hyperactivity Disorder ... and caregivers of patients with Attention deficit Hyperactivity Disorder (ADHD), as well as adults ... M.D., director of the Adult Attention deficit Disorder Center of Maryland and assistant ...BioSpecifics Technologies Corp. Reports Second Quarter 2008 Financial Results
... 1,261,211 Liabilities and Stockholders' deficit Current liabilities: Accounts payable and ... 1,092,925 4,751,447 Accumulated deficit (11,437,876) ... - (625,774) Total stockholders' deficit (1,387,399) (6,735,658) ...Kiwa Bio-Tech 2nd Quarter Revenues Increase 61.7% to $3 Million, Six Month Revenues Top $5.2 Million
... minority interest in a subsidiary's deficit (640,744) (893,134) (1,343,184) ... Minority interest in a subsidiary's deficit 9,723 750 25,968 ... reserve (224,764) (307,053) deficit accumulated (12,391,738) ...SemBioSys announces second quarter 2008 financial and operational results
... debenture 1,427,127 - deficit ... Statements of Loss, Comprehensive Loss and deficit (Unaudited) ... (3,225,371) (11,431,911) (6,453,782) deficit - Beginning of period (61,176,218) ...... (lisdexamfetamine dimesylate) - Attention deficit and Hyperactivity Disorder ("ADHD") - On ... Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic ... (lisdexamfetamine dimesylate) (Attention deficit and Hyperactivity Disorder ("ADHD")); the impact ...
Bioheart, Inc. Announces Financial Results for Second Quarter 2008
... LIABILITIES AND SHAREHOLDERS' deficit Current liabilities Accounts payable ... Commitments and contingencies Shareholders' deficit Preferred stock ($0.001 par value) 5,000,000 ... 79,835,158 77,061,296 deficit accumulated during the development stage ...... patients with tools and resources about Attention deficit Hyperactivity Disorder (ADHD). The newly enhanced ... and CEO of the national Attention deficit Disorder Association (ADDA), psychologist and ... 20th annual Children and Adults with Attention deficit Hyperactivity Disorder (CHADD) international ...
Galaxy Nutritional Foods Reports FY2008 Results
... $ 4,364,618 LIABILITIES AND STOCKHOLDERS' deficit CURRENT LIABILITIES: Secured borrowings ... 70,167,149 70,167,149 Accumulated deficit (70,970,948) (72,309,803) Total stockholders' deficit (632,699) (1,971,554) ...Advance Nanotech Reports First Quarter 2008 Financial Results
... 7,187,471 6,854,191 STOCKHOLDERS' deficit Preferred stock; $0.001 par value; 25,000,000 ... loss (1,372,437) (801,386) deficit accumulated during development stage ... (31,911,750) (30,826,109) TOTAL STOCKHOLDERS' deficit (15,829,177) (12,753,808) ...Bioheart, Inc. Announces Financial Results for First Quarter 2008
... LIABILITIES AND SHAREHOLDERS' deficit Current liabilities Accounts payable ... Commitments and contingencies Shareholders' deficit Preferred stock ($0.001 par value) ... 78,720,440 77,061,296 deficit accumulated during the development stage ...Vermillion Announces First Quarter 2008 Financial Results and Business Progress
... $24,053 Liabilities and Stockholders' deficit Current liabilities: Accounts payable ... 228,067 227,895 Accumulated deficit (243,988) ... (640) (221) Total stockholders' deficit (16,555) (11,462) ...Shire Launches Nationwide Adult ADHD Mobile Awareness Tour
... screening initiative for adults with Attention deficit Hyperactivity Disorder (ADHD), a ... Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic ... dimesylate) (Attention deficit and Hyperactivity Disorder ("ADHD")); the impact ...SemBioSys announces first quarter 2008 financial and operational results
... 7,506,865 7,326,962 deficit (61,176,218) ... Statements of Loss, Comprehensive Loss and deficit (Unaudited) ... (5,017,055) (3,228,411) deficit - Beginning of period (56,159,163) ...Publication of Supplementary Prospectus
... Application for use in the treatment of Attention deficit Hyperactivity Disorder in adults, which was ... Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic ... dimesylate) (Attention deficit and Hyperactivity Disorder ("ADHD")); the impact ...Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance
... Product Highlights VYVANSE(TM) - Attention deficit and Hyperactivity Disorder ("ADHD") - By April ... Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic ... dimesylate) (Attention deficit and Hyperactivity Disorder ("ADHD")); the impact ...... of Medicine and director of the Adult Attention deficit Disorder Center of Maryland. "The good news is ... Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic ... dimesylate) (Attention deficit and Hyperactivity Disorder ("ADHD")); the impact ...
Kiwa Bio-Tech Year-End Revenues Increase 264% - Exceed $9.1 Million
... Loss before minority interest in a subsidiary's deficit (2,893,027) (2,541,502) Minority interest in a subsidiary's deficit (332) ... reserve (307,053) (523,468) deficit accumulated (11,074,522) ...SemBioSys announces 2007 financial and operational results
... 7,326,962 5,475,404 deficit ... Statements of Loss, Comprehensive Loss and deficit For the years ended December 31, ... loss for the year (15,418,677) (14,127,086) deficit - Beginning of year ...NPS Pharmaceuticals Reports 2007 Financial Results
... (2,504) (1,892) Accumulated deficit (869,529) (868,872) Total stockholders' deficit (188,031) (193,244) Total liabilities and stockholders' deficit $231,757 $224,740 * Non-recourse debt ...Spectral announces 2007 financial results
... 5,606 5,489 deficit ... of Operations, Comprehensive (Loss) Income and deficit ... (1,666) 3,730 deficit - Beginning of period ...... Liabilities and Stockholders' deficit Current liabilities: Accounts payable ... 227,895 207,991 Accumulated deficit (239,142) ... (221) (71) Total stockholders' deficit (11,462) (9,901) ...
... Product Highlights - VYVANSE(TM) - Attention deficit and Hyperactivity Disorder ("ADHD"). - Approved ... Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic ... dimesylate) (Attention deficit and Hyperactivity Disorder ("ADHD")); the impact ...
... additional dosage strengths for the attention deficit hyperactivity disorder (ADHD) treatment, ... Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic ... dimesylate) (Attention deficit and Hyperactivity Disorder ("ADHD")); the impact ...
NPS Pharmaceuticals Reports Third Quarter 2007 Financial Results, Revises Financial Guidance
... (500) (1,892) Accumulated deficit (890,734) (868,872) Net stockholders' deficit (209,698) (193,244) Total liabilities and stockholders' deficit $361,489 $224,740 About NPS ...SemBioSys announces 2007 third quarter results
... 6,026,443 5,475,404 deficit ... Statements of Loss, Comprehensive Loss and deficit (Unaudited) ... (2,659,025) (10,134,732) (9,771,546) deficit - Beginning of period (47,194,268) ...Shire Divests Non-Core Product Portfolio to Almirall
... Shire's focus is on building its attention deficit hyperactivity disorder (ADHD), human genetic ... Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic ... to the impact of those on Shire's Attention deficit and Hyperactivity Disorder (ADHD) franchise; ...Celebrity Designer Ty Pennington to Host 'ADHD Experts on Call' Program
... ADHD Experts to Answer Questions about Attention deficit Hyperactivity Disorder ... Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic ... to the impact of those on Shire's Attention deficit and Hyperactivity Disorder ("ADHD") franchise; ...WuXi PharmaTech Announces Second Quarter 2007 Results
... Liabilities, mezzanine equity and shareholders' deficit Current liabilities: Short-term bank ... (360) (360) Total shareholders' deficit (33,492) (928) ... mezzanine equity and shareholders' deficit 151,886 85,691 Note 1: Eight ...InterMune Reports Second Quarter 2009 Financial Results and Business Highlights
... senior notes 130,471 155,084 Stockholders' deficit (80,642) (110,371) ... -------- Total liabilities and stockholders' deficit $165,647 $171,810 ...... liabilities 4,849 4,933 Stockholders' deficit (297,044) (299,873) ... Total liabilities and stockholders' deficit $ 382,320 $ 385,197 ...
... 64,243 Convertible debt 66,391 142,373 Accumulated deficit (1,352,870) (1,312,320) Total deficit (57,630) (132,061) (1) Amounts reflect a one-for-ten ...
Shire plc: Core Portfolio of Products Delivers 20% Sales Growth
... to assess the efficacy and safety of VYVANSE in non ADHD ("Attention deficit Hyperactivity Disorder") indications. Our HGT pipeline has been ... comprehensive income 119.7 97.0 Accumulated deficit (843.8) (1,051.7) Total Shire plc ...Vasogen Announces Second Quarter 2009 Results
... surplus 24,121 23,555 deficit (401,193) (397,857) ... STAGE COMPANY) Interim Consolidated Statements of Operations, deficit and Comprehensive Income (In thousands of Canadian dollars, except ...Other Contentsdeathdeathdeathdeathdeathdeathdeathdeathdeathprogrammedprogrammedprogrammedprogrammedprogrammedprogrammedprogrammedprogrammedprokaryotesprokaryotesprokaryotesprokaryotesproofproofproofproofproofproofprostaglandinsprostaglandinsprostateprostateprostateprostateprostateprostateprostatearrayarrayarrayarrayarrayarrayarrayarray
Breaking Biology News(10 mins):Europe's flora is becoming impoverished 2Europe's flora is becoming impoverished 3New inherited eye disease discovered 2Introns: A mystery renewed 2Introns: A mystery renewed 3Introns: A mystery renewed 4Breast Feeding May Lower Breast Cancer Risk 54103 1Breast Feeding May Lower Breast Cancer Risk 54103 2Breast Feeding May Lower Breast Cancer Risk 54103 320 20 Tackles Taboo Health Issue Affecting Millions of Women 54099 120 20 Tackles Taboo Health Issue Affecting Millions of Women 54099 2Inaugural Medical Device Connectivity Conference 26 Exhibition to Focus on Connecting Medical Devices to People Workflow and Information Systems 54095 1Inaugural Medical Device Connectivity Conference 26 Exhibition to Focus on Connecting Medical Devices to People Workflow and Information Systems 54095 2
Breaking Medicine News(10 mins):Health News:Tweaks to Breast Cancer Treatments Boost Outcomes 2Health News:Tweaks to Breast Cancer Treatments Boost Outcomes 3Health News:Effort to Regenerate Injured Spinal Cords Turns to a New Model 2Health News:Effort to Regenerate Injured Spinal Cords Turns to a New Model 3Health News:Effort to Regenerate Injured Spinal Cords Turns to a New Model 4Health News:Alcohol Countermeasure Systems Penetrates New Markets Through Acquisition of Seres Ethylometre of France 2Health News:New Hope for Brain, Spinal Cord Injuries 2
Other TagsPRECIPITATIONDiscDiscDiscDiscDiscDiscDiscPGCTRACTRACTRACTRACTRACTRACTRACTRACNuncNuncOpaque[0] Tweaks to Breast Cancer Treatments Boost Outcomes[0] Stem Cells Turned Into AIDS Killers in Lab Tests[0] Effort to Regenerate Injured Spinal Cords Turns to a New Model[0] Alcohol Countermeasure Systems Penetrates New Markets Through Acquisition of Seres Ethylometre of France[0] New Hope for Brain, Spinal Cord Injuries
ThermocylcerPRECIPITATIONDiscSPRPlateinL10ScientificsPGCComposerTRACOmniTrayNuncCentrifugaliBLOXOpaque
Other Tagstrainee 2someday 2destroying 2destroying 3destroying 4destroying 5educate 2educate 3educate 4educate 5educate 6educate 7educate 8educate 9dietary 2dietary 3dietary 4susceptible 2susceptible 3susceptible 4susceptible 5susceptible 6susceptible 7susceptible 8susceptible 9susceptible 10weigh 2| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |